BioSpace News Archive

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that the company will release its second quarter 2020 financial results after the market closes on Thursday, August 13, 2020. Management will host a conference call with a slide presentation at 5:00 p.m. ET (2:00 p.m. PT) on the same day to provide an update on

CARISMA Therapeutics Inc. , a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two virtual conferences in August 2020 .

EVERSANA™, the leading provider of commercial services to the life science industry, and Havas Health & You (HH&Y), the world’s largest global health and wellness network, today announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and wellness clients worldwide.

Today Essity, a leading global hygiene and health company and the maker of TENA incontinence and skin care products announced new findings from a recent consumer survey of incontinence sufferers that uncovered a surprising truth: most women are living with intimate skin irritation, yet are not using the right incontinence products or addressing these issues with their doctor

March of Dimes, the nation’s leader in the fight for the health of all moms and babies, is pleased to announce the availability of funds for research grants to address the heath threats facing pregnant women and babies during the COVID

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced tha

Britta Will, Ph.D., assistant professor of medicine and of cell biology at Albert Einstein College of Medicine, has won a 2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research.

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting cancers caused by dysregulated gene expression, today announced the pricing of an underwritten public offering of 4,461,209 shares of its common stock at a price to the public of $1.20 per share. All of the shares are being sold by Salarius. The gross proceeds to Salarius from the offering, before deducting the underwriting discounts and commissions and other

Cerus Corporation (Nasdaq:CERS) today announced it has been awarded a five-year tender by the Hong Kong Red Cross Blood Transfusion Services (BTS) for INTERCEPT Blood System for platelets. The Hong Kong Red Cross BTS is the only public institution providing blood to all hospitals, public and private, in Hong Kong. “Following a thorough selection process, we are pleased to be selected by the Hong Kong Red Cross BTS t

Australian drug development company Kira Biotech, with a mission to bring new treatment options to patients with autoimmune and inflammatory conditions, has announced the appointment of Michael Grissinger as independent Chair of its Board of Directors. Michael has had a highly successful career in senior business and corporate development roles within global pharmaceutical companies. He spent 22 years at Johnson